- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05091658
Period Tracker Lay User Study
November 23, 2021 updated by: SPD Development Company Limited
This study will assess the ability of the lay user to obtain and record a result.
Comprehension of the instructions for use of the product will also be assessed.
Study Overview
Study Type
Observational
Enrollment (Actual)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bedfordshire
-
Bedford, Bedfordshire, United Kingdom, MK44 3UP
- SPD Development Company Ltd
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women between the ages of 18 to 45 represent the intended user of the product
Description
Inclusion Criteria:
- Female
- Aged 18 to 45 years
- Willing to give informed consent and comply with the investigational procedures
Exclusion Criteria:
- Used Clearblue® me Period Tracker app Persona or FAM within the last six months
- Currently or previously employed by SPD, Abbott, Alere, Unipath, P&G or affiliates
- Has an immediate* relative currently or previously (within past 5 years) employed by SPD, Abbott, Alere, Unipath or P&G, or affiliates
- Is a qualified or trainee healthcare professional (HCP)
- Has professional experience of using dipstick type tests or lateral flow devices
- Currently breastfeeding, pregnant or seeking to conceive
- Currently menstruating∆ *Immediate relatives are defined as parents, children, siblings or partner/spouse ∆Volunteer can start the study when their period has ended.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lay user usage
Time Frame: 1 hour
|
Ability of the lay user to perform a test and record their result
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comprehension of instructions for use
Time Frame: 1 hour
|
Ability of the lay user to understand the information provided in the instructions for use
|
1 hour
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lay user ability to read a high and a low result
Time Frame: 1 hour
|
Ability of the lay user to score a positive result above a baseline result using the product scoring scale
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sharon Bond, SPD Development Company
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 14, 2021
Primary Completion (ACTUAL)
November 10, 2021
Study Completion (ACTUAL)
November 10, 2021
Study Registration Dates
First Submitted
October 12, 2021
First Submitted That Met QC Criteria
October 12, 2021
First Posted (ACTUAL)
October 25, 2021
Study Record Updates
Last Update Posted (ACTUAL)
November 24, 2021
Last Update Submitted That Met QC Criteria
November 23, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- PROTOCOL-1337
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No plan to share individual participant data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menstrual Cycles
-
SPD Development Company LimitedCompleted
-
SPD Development Company LimitedCompleted
-
Izmir University of EconomicsCompleted
-
Oregon Health and Science UniversitySociety of Family PlanningCompletedOvulation (Follicular Rupture Yes/no) | Menstrual Cycles (Total Length, Bleeding Days) | Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P)United States
-
National Institute of Environmental Health Sciences...Active, not recruitingMenstrual Cycles | Conception | Early Pregnancy Loss | Pregnancy OutcomesUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownProgesterone,Hormone Replacement Thawed Embryo Transfer Cycles
-
Reproductive Medicine Associates of New JerseyCompletedEffect of PGD on Implantation Rates in IVF CyclesUnited States
-
Taipei Medical University WanFang HospitalCompletedIrregular Menstrual Cycle | Regular Menstrual CycleTaiwan
-
Hülya ULAŞLI KABANNot yet recruitingDisabled People | Menstrual Hygiene Management | Menstrual Cup
-
Shaare Zedek Medical CenterActive, not recruitingUse of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF CyclesIsrael
Clinical Trials on LH Urine Test
-
SPD Development Company LimitedCompleted
-
Amnon ZungUnknownPrecocious Puberty, Gonadotropin-dependentIsrael
-
Peking Union Medical College HospitalActive, not recruitingHepatitis B | Hepatocellular CarcinomaChina
-
Chinese University of Hong KongRecruitingCommunity-acquired PneumoniaHong Kong
-
University of Cape TownUniversity of Zimbabwe; University of Zambia; NIMR - Mbeya Medical Research ProgrammeCompletedTuberculosisZambia, Zimbabwe, South Africa, Tanzania
-
Pacific Edge LimitedRecruitingUrothelial CarcinomaUnited States
-
Kendall Healthcare Group, Ltd.CompletedAsymptomatic Bacteriuria | Asymptomatic PyuriaUnited States
-
Oslo University HospitalThe Research Council of Norway; Haukeland University Hospital; St. Olavs Hospital and other collaboratorsActive, not recruitingUrinary Bladder Neoplasms | Non-Muscle Invasive Bladder Neoplasms | Carcinoma, Transitional Cell, BladderNorway
-
Hospices Civils de LyonUnknownDrug AbortionFrance